Finally, we show in two randomized clinical trials (RCT) of stage III CRC, altogether encompassing over 3000 patients, that the PrPC-dependent axis is pathognomonic of the CMS4 subtype and is associated with dismal prognosis. This evidence concerns the gene PRNP and colorectal carcinoma.